|Articles|April 1, 2019
- Pharmaceutical Executive-04-01-2019
- Volume 39
- Issue 4
Pharmaceutical Executive, April 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Biosimilars Name Game Remains Thorny Issuealmost 7 years ago
HBA's Woman of the Year 2019almost 7 years ago
Sharing Your Voicealmost 7 years ago
Health Technology’s Double-Edged Swordalmost 7 years ago
True Grit: Talent Management from the Ground Upalmost 7 years ago
Reinventing Pharma’s Talent Searchalmost 7 years ago
Hiring a Chief Diversity Officeralmost 7 years ago
Are Pharma Marketers Fighting the Last War?almost 7 years ago
Ready Patient Onealmost 7 years ago
Country Report: ChinaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5